398
Views
30
CrossRef citations to date
0
Altmetric
Technology Profile

Affymetrix GeneChip® system: moving from research to the clinic

&
Pages 145-152 | Published online: 09 Jan 2014

References

  • Elvidge GP. Microarray expression technology: from start to finish. Pharmacogenomics 7(1), 123–134 (2006).
  • Dong S, Wang E, Hsie L, Cao Y, Chen X, Gingeras TR. Flexible use of high-density oligonucleotide arrays for single-nucleotide polymorphism discovery and validation. Genome Res. 11(8), 1418–1424 (2001).
  • Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nature Genet. 37(10), 1099–1103 (2005).
  • Herr A, Grutzmann R, Matthaei A et al. High-resolution analysis of chromosomal imbalances using the Affymetrix 10K SNP genotyping chip. Genomics 85(3), 392–400 (2005).
  • Kim J, Bhinge AA, Morgan XC, Iyer VR. Mapping DNA–protein interactions in large genomes by sequence tag analysis of genomic enrichment. Nature Methods 2(1), 47–53 (2005).
  • Galvin P, Clarke LA, Harvey S, Amaral MD. Microarray analysis in cystic fibrosis. J. Cyst. Fibros. 3(Suppl. 2), 29–33 (2004).
  • Syvanen AC. From gels to chips: ‘minisequencing’ primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum. Mutat. 13(1), 1–10 (1999).
  • Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res. 10(7), 1031–1042 (2000).
  • Cutler DJ, Zwick ME, Carrasquillo MM et al. High-throughput variation detection and genotyping using microarrays. Genome Res. 11(11), 1913–1925 (2001).
  • Fan JB, Chen X, Halushka MK et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res. 10(6), 853–860 (2000).
  • Syvanen AC. Toward genome-wide SNP genotyping. Nature Genet. 37(Suppl.), S5–S10 (2005).
  • Hacia JG. Resequencing and mutational analysis using oligonucleotide microarrays. Nature Genet. 21(1 Suppl.), 42–47 (1999).
  • Karaman MW, Groshen S, Lee CC, Pike BL, Hacia JG. Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays. Nucleic Acids Res. 33(3), e33 (2005).
  • Chou WH, Yan FX, Robbins-Weilert DK et al. Comparison of two CYP2D6 genotyping methods and assessment of genotype–phenotype relationships. Clin. Chem. 49(4), 542–551 (2003).
  • Maitra A, Cohen Y, Gillespie SE et al. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. 14(5), 812–819 (2004).
  • Cronin MT, Fucini RV, Kim SM, Masino RS, Wespi RM, Miyada CG. Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays. Hum. Mutat. 7(3), 244–255 (1996).
  • Lehman TA, Haffty BG, Carbone CJ et al. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res. 60(4), 1062–1069 (2000).
  • Wikman FP, Lu ML, Thykjaer T et al. Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin. Chem. 46(10), 1555–1561 (2000).
  • Cooper M, Li SQ, Bhardwaj T, Rohan T, Kandel RA. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens. Clin. Chem. 50(3), 500–508 (2004).
  • Fang NY, Greiner TC, Weisenburger DD et al. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc. Natl Acad. Sci. USA 100(9), 5372–5377 (2003).
  • Shrimpton AE, Levinsohn EM, Yozawitz JM et al. A HOX gene mutation in a family with isolated congenital vertical talus and Charcot–Marie–Tooth disease. Am. J. Hum. Genet. 75(1), 92–96 (2004).
  • Uhlenberg B, Schuelke M, Ruschendorf F et al. Mutations in the gene encoding gap junction protein α 12 (connexin 46.6) cause Pelizaeus–Merzbacher-like disease. Am. J. Hum. Genet. 75(2), 251–260 (2004).
  • Sawcer SJ, Maranian M, Singlehurst S et al. Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. Hum. Mol. Genet. 13(17), 1943–1949 (2004).
  • Butcher LM, Meaburn E, Liu L et al. Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav. Genet. 34(5), 549–555 (2004).
  • Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Ann. Rev. Pharmacol. Toxicol. 37, 269–296 (1997).
  • Ishida S, Soyama A, Saito Y et al. Determination of CYP2D6 gene alleles by the CYP450 probe array using the Affymetrix GeneChip system: comparison with sequencing results. Drug Metab. Pharmacokinet. 17(2), 157–160 (2002).
  • Pollack JR, Perou CM, Alizadeh AA et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23(1), 41–46 (1999).
  • Bignell GR, Huang J, Greshock J et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. 14(2), 287–295 (2004).
  • Rauch A, Ruschendorf F, Huang J et al. Molecular karyotyping using an SNP array for genomewide genotyping. J. Med. Genet. 41(12), 916–922 (2004).
  • Cox C, Bignell G, Greenman C et al. A survey of homozygous deletions in human cancer genomes. Proc. Natl Acad. Sci. USA 102(12), 4542–4547 (2005).
  • Schoumans J, Nielsen K, Jeppesen I et al. A comparison of different metaphase CGH methods for the detection of cryptic chromosome aberrations of defined size. Eur. J. Hum. Genet. 12(6), 447–454 (2004).
  • Slater HR, Bailey DK, Ren H et al. High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am. J. Hum. Genet. 77(5), 709–726 (2005).
  • Selzer RR, Richmond TA, Pofahl NJ et al. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44(3), 305–319 (2005).
  • Ishkanian AS, Malloff CA, Watson SK et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genet. 36(3), 299–303 (2004).
  • Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439), 531–537 (1999).
  • van ’t Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871), 530–536 (2002).
  • Pomeroy SL, Tamayo P, Gaasenbeek M et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415(6870), 436–442 (2002).
  • Beer DG, Kardia SL, Huang CC et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8(8), 816–824 (2002).
  • Call DR. Challenges and opportunities for pathogen detection using DNA microarrays. Crit. Rev. Microbiol. 31(2), 91–99 (2005).
  • Wilson JW, Ramamurthy R, Porwollik S et al. Microarray analysis identifies Salmonella genes belonging to the low-shear modeled microgravity regulon. Proc. Natl Acad. Sci. USA 99(21), 13807–13812 (2002).
  • Zwick ME, Mcafee F, Cutler DJ et al. Microarray-based resequencing of multiple Bacillus anthracis isolates. Genome Biol. 6(1), R10 (2005).
  • Hess S, Peters J, Bartling G et al. More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation. Cell Microbiol. 5(11), 785–795 (2003).
  • Nau GJ, Schlesinger A, Richmond JF, Young RA. Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria. J. Immunol. 170(10), 5203–5209 (2003).
  • Sosnowski RG, Tu E, Butler WF, O’Connell JP, Heller MJ. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proc. Natl Acad. Sci. USA 94(4), 1119–1123 (1997).
  • Erali M, Schmidt B, Lyon E, Wittwer C. Evaluation of electronic microarrays for genotyping Factor V, Factor II, and MTHFR. Clin. Chem. 49(5), 732–739 (2003).
  • Ferrari M, Cremonesi L, Bonini P, Foglieni B, Stenirri S. Single-nucleotide polymorphism and mutation identification by the nanogen microelectronic chip technology. Methods Mol. Med. 114, 93–106 (2005).
  • Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res. 33(18), 5914–5923 (2005).
  • Lips EH, Dierssen JW, van Eijk R et al. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res. 65(22), 10188–10191 (2005).
  • Roses AD. Genetic testing for Alzheimer’s disease. Practical and ethical issues. Arch. Neurol. 54(10), 1226–1229 (1997).
  • Euhus DM, Smith KC, Robinson L et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J. Natl Cancer Inst. 94(11), 844–851 (2002).

Websites

  • Affymetrix: Products and Applications www.affymetrix.com/products
  • Affymetrix: Tools www.affymetrix.com/support/developer/tools/affytools.affx
  • Guidance for Industry: Pharmacogenomic Data Submissions www.fda.gov/cber/gdlns/pharmdtasub.pdf
  • Affymetrix: Standards Program www.affymetrix.com/community/standards/index.affx

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.